☆ 4.7 Editorial Material

Clostridium difficile infection trials: what is the primary endpoint?

LANCET INFECTIOUS DISEASES (2019)

Journal

LANCET INFECTIOUS DISEASES

Volume 19, Issue 3, Pages 219-220

Publisher

ELSEVIER SCI LTD

DOI: 10.1016/S1473-3099(18)30626-1

Keywords

-

Categories

Infectious Diseases

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.